Experience with monovalent and bivalent influenza vaccines in Canada 1976.
Laboratory examination of vaccines from four manufacturing companies and prepared with A/New Jersey/8/76 and A/Victoria/3/75 strains (clinical results, cf. these proceedings, pp. 267-272). When diluting the concentrated suspensions of vaccine, loss of activity can be avoided by adding a small amount of Tween 80 to the diluent.
D002170:Canada; D004345:Drug Industry; D005557:Formaldehyde; D009980:Influenza A virus; D007252:Influenza Vaccines / Q000592:standards*; D011136:Polysorbates; D011420:Propiolactone
D007252:Influenza Vaccines; D011136:Polysorbates; D005557:Formaldehyde; D011420:Propiolactone